Cancer BiologybioRxivPreprint
A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer
E. Lee, S. Archasappawat, K. Ji…·C.-i. Hwang
This study identifies BET inhibition as a potential therapy for BRCA2-deficient pancreatic cancer by showing it enhances autophagy-dependent cell death in these cells.
DOI 10.1101/2023.05.30.542934